Company Taro Pharmaceutical Industries Ltd. Other OTC

IL0010827181

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

End-of-day quote Other OTC Other stock markets
- ^USD	-

06-25	Taro Pharmaceutical Industries Ltd.(NYSE:TARO) dropped from S&P Global BMI Index	CI
06-24	Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	CI

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.

Managers	Title	Age	Since
Uday Vijaykumar Baldota CEO	Chief Executive Officer	54	30/11/16
William Coote DFI	Director of Finance/CFO	69	31/12/07
Richard Glaze CTO	Chief Tech/Sci/R&D Officer	58	-
Hagai Reingold COO	Chief Operating Officer	-	31/12/01
Avi Avramoff CTO	Chief Tech/Sci/R&D Officer	59	30/09/11
James Kedrowski BRD	Director/Board Member	72	30/09/10
David Kinzelberg AUD	Comptroller/Controller/Auditor	-	-
Erik Zwicker LAW	General Counsel	44	12/04/20
Abhay Gandhi PRN	Corporate Officer/Principal	59	30/11/16
Michele Visosky HRO	Human Resources Officer	58	31/12/03

Members of the board	Title	Age	Since
Robert Stein BRD	Director/Board Member	73	31/01/20
Dilip Shantilal Shanghvi CHM	Chairman	68	21/09/10
Sudhir Vrundavandas Valia BRD	Director/Board Member	67	31/08/10
Oded Sarig BRD	Director/Board Member	69	26/06/23
Uday Vijaykumar Baldota CEO	Chief Executive Officer	54	30/11/16
James Kedrowski BRD	Director/Board Member	72	30/09/10
Linda Ben Shoshan BRD	Director/Board Member	59	30/11/16

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	3,719	2,600	0	0	17.92 %
Stock B	1	45,116,262	8,086,818 ( 17.92 %)	7,531,631 ( 16.69 %)

Taro Pharmaceutical Industries Ltd.

14 Hakitor Street

2624761, Haifa Bay

+972 4 847 5700

http://www.taro.com

address Taro Pharmaceutical Industries Ltd.

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+62.04%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-4.12%	359B
MERCK & CO., INC.	+15.40%	325B
ABBVIE INC.	+9.05%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.89%	177B
PFIZER, INC.	+2.22%	165B

Other Pharmaceuticals